SCHEMBL4773025

SCHEMBL4773025

c1ccc(-c2nc(NC3CCOCC3)cc(-c3cccnc3)n2)nc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
TP53 P04637 1/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
KCNH2 Q12809 6/20 0.45
ATM Q13315 3/20 0.44
ATR Q13535 1/20 0.44
GPR39 O43194 1/20 0.43
PIK3CA P42336 2/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43
CHRM4 P08173 1/20 0.42
HIF1A Q16665 1/20 0.41
JAK1 P23458 1/20 0.41
JAK3 P52333 1/20 0.41
F12 P00748 1/20 0.41
PRKD1 Q15139 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4775378 0.87 MERTK (0.52) CYP2A6SMN1; SMN2NPC1TP53PKM
SCHEMBL4773261 0.79 SYK (0.47) CYP2A6SMN1; SMN2NPC1TP53PKM
SCHEMBL4878463 0.79 SYK (0.47) CYP2A6SMN1; SMN2NPC1TP53PKM
SCHEMBL4772988 0.79 CYP2A6 (0.45) CYP2A6SMN1; SMN2NPC1TP53PKM
SCHEMBL4775400 0.78 GBA1 (0.53) CYP2A6SMN1; SMN2NPC1TP53PKM
SCHEMBL2239462 0.75 ATR (0.49) ATRPIK3CALRRK2
SCHEMBL2238528 0.74 CYP1A2 (0.50) SMN1; SMN2NPC1TP53PKMTSHR
SCHEMBL2240097 0.74 TGFBR1 (0.52) ATR
SCHEMBL4773053 0.74 MTOR (0.44) SMN1; SMN2NPC1TP53PKMTSHR
SCHEMBL19498476 0.73 CARM1 (0.43) KCNH2ATMATRPIK3CAPDE1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1878733-A1 Pyrimidine derivatives as ALK-5 inhibitors Novartis AG (CH) 2008-01-16 EP disclosed